DESONATE 0.05% LOTION contains Desonide which belongs to a group of medicines called Topical Corticosteroids. DESONATE 0.05% LOTION is used to relieve inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis.
Along with this treatment, your doctor might advise you to take a urinary-free cortisol and ACTH (adrenocorticotropic hormone) stimulation test to evaluate HPA axis suppression (a condition that causes poor body defence against infection) especially in children to prevent its effect in the body.
Before applying DESONATE 0.05% LOTION, inform your doctor if you are allergic to Desonide or any other ingredients in the medicine, and or have concomitant skin infections (infections caused by parasites).
DESONATE 0.05% LOTION should be used in pregnant and breastfeeding women only if it is necessary. Consult your doctor for advice.
DESONATE 0.05% LOTION is not recommended for use in children (less than 2 years of age). Consult your doctor before applying DESONATE 0.05% LOTION.
The most common side effects of applying DESONATE 0.05% LOTION are application site reactions such as burning, irritation, itching and redness, headache. Contact your doctor if any of the side effects get worse.
DESONATE 0.05% LOTION works by the induction of lipocortins (inflammatory enzyme) that results in the decreased biosynthesis of prostaglandins and leukotrienes (potent mediators of inflammation) which prevents the release of arachidonic acid (hormone responsible for inflammatory process in the skin) thus providing relief from the inflammation, redness, and itching sensation.
Apply DESONATE 0.05% LOTION as directed by your doctor. It is for external use only. Avoid contact of this medicine in your eyes, ears, nose, mouth, or mucous membrane. Your doctor will decide the duration of treatment depending on the severity of the condition.
Stop applying DESONATE 0.05% LOTION and contact your doctor immediately if you experience any of the following side effects:
Headache:
If DESONATE 0.05% LOTION cause headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of applying DESONATE 0.05% LOTION. If headaches last more than a week or severe, inform your doctor.
DESONATE 0.05% LOTION should be used in pregnant women only if it is clearly advised by your doctor. Consult your doctor before using DESONATE 0.05% LOTION.
DESONATE 0.05% LOTION should be used in breastfeeding women only if clearly advised by your doctor. Do not apply DESONATE 0.05% LOTION to the breasts during lactation since it might lead to risk of ingestion by the neonate. Consult your doctor before applying DESONATE 0.05% LOTION.
DESONATE 0.05% LOTION does not interfere with your ability to drive or use heavy machines. Consult your doctor before applying DESONATE 0.05% LOTION.
Avoid or limit the consumption of alcohol while applying DESONATE 0.05% LOTION. Consult your doctor for advice.
Do not use DESONATE 0.05% LOTION if you are allergic to Desonide or any other ingredients in the medicine. Consult your doctor before applying DESONATE 0.05% LOTION.
DESONATE 0.05% LOTION is not recommended for use if you:
Before applying DESONATE 0.05% LOTION, inform your doctor if you have:
Use in pediatrics:
DESONATE 0.05% LOTION is not recommended for use in children (less than 2 years of age). Your doctor will prescribe the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before applying DESONATE 0.05% LOTION.
Use in geriatrics:
DESONATE 0.05% LOTION should be used with caution in elderly patients (above 65 years of age). Consult your doctor before applying DESONATE 0.05% LOTION.
A. Drug-Drug Interactions:
Before applying DESONATE 0.05% LOTION, inform your doctor, if you are taking or using prescription, non-prescription and herbal medicines.
Overdosage:
If you or anyone else accidentally uses too much DESONATE 0.05% LOTION, consult your doctor immediately or visit the nearby hospital.
Drug | : | Desonide |
Pharmacological Category | : | Topical Corticosteroids |
Therapeutic Indication | : | Corticosteroid-responsive dermatoses (skin disorder characterized by itchy scalp and red skin) |
Dosage Forms | : | Cream, Lotion, Gel |
What DESONATE 0.05% LOTION is used for?
DESONATE 0.05% LOTION is used to relieve inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis.
How DESONATE 0.05% LOTION is applied on the affected site?
Apply DESONATE 0.05% LOTION as directed by your doctor. It is for external use only. Wash your hands before and after use to ensure hygiene is maintained. Your doctor will decide the duration of treatment depending on the severity of the condition.
What are the side effects of DESONATE 0.05% LOTION?
The most common side effects of applying DESONATE 0.05% LOTION are application site burning and irritation, headache, high blood pressure, and red skin. Contact your doctor if any of the side effects worsen.
Is DESONATE 0.05% LOTION safe to use in children?
DESONATE 0.05% LOTION is not recommended for use in children (less than 2 years of age) and is advised to be used with caution in children (above 2 years) and adolescents (less than 18 years) after consult your doctor before applying DESONATE 0.05% LOTION who might check for any occurrence of side effects.
1. KD. Tripathi. Drugs Acting on Skin and Mucous Membranes. Essentials of medical pharmacology. Seventh edition. 2013. Page – 895.
2. Wake Forest University. Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects with Atopic Dermatitis. NIH U.S. National Library of Medicine. ClinicalTrials.gov. [Revised in September 2018] [Accessed on 6th May 2022] https://clinicaltrials.gov/ct2/show/NCT00690833
3. Sarah Gabros; Trevor A. Nessel; Patrick M. Zito. Topical Corticosteroids. NIH National Library of Medicine. National Center for Biotechnology Information. StatPearls. November 2021 [Accessed on 6th May 2022] https://www.ncbi.nlm.nih.gov/books/NBK532940/
4. Galderma Australia Pty Ltd. DESOWEN. [Revised in August 2018] [Accessed on 6th May 2022] https://www.galderma.com/au/sites/default/files/inline-files/Desowen%20PI_7%20Aug%202018_0.pdf
5. Stiefel Laboratories, Inc. U.S. Food & Drug Administration. [Revised in April 2013] [Accessed on 6th May 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021978s010lbl.pdf
6. Bayer HealthCare Pharmaceuticals Inc. U.S. Food & Drug Administration. [Revised in July 2014] [Accessed on 6th May 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021844s008lbl.pdf
Written By Dr. Janet.C, Pharm.D
Last updated on 30 Nov 2022 | 12:23 PM(IST)
Additional Discount on this product
Please get a call back from our expert
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.